Enliven Therapeutics (ELVN) Total Non-Current Liabilities (2019 - 2026)
Enliven Therapeutics (ELVN) recorded Total Non-Current Liabilities of $14.16 million in Q2 2026, down 6.9% from $15.21 million a year earlier.
Powered by 
Analysis
Enliven Therapeutics (ELVN) Total Non-Current Liabilities (2019 - 2026) Analysis & Trends
At the end of FY2025, Enliven Therapeutics reported Total Non-Current Liabilities of $16.57 million, up 4.1% from FY2024.
- Annual Total Non-Current Liabilities has a five-year compound annual growth rate of 21.5% (FY2020 to FY2025).
- Across earlier years, Total Non-Current Liabilities came in at $15.92 million in FY2024 (-38.5%), $25.89 million in FY2023 (-83.8%) and $159.46 million in FY2022.
- The Q2 2026 figure is the lowest quarterly Total Non-Current Liabilities since Q1 2025.
- On a year-over-year basis, Total Non-Current Liabilities rose in two of the last seven quarters, with an average decline of 12.8%.
- Peak year-over-year performance for Total Non-Current Liabilities in the last five years was growth of 141.7% in Q2 2024, against a decline of 83.8% in Q4 2023 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 105.99 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 106.45 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 80.25 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 48.34 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -967.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 81.11 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 36.04 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 100.86 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 5.92 Bn |
| 10 | Enliven Therapeutics | 3.36 Bn | 3.36 Bn | - | 14.16 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 14.16 Mn |
| Dec 31, 2025 | 16.57 Mn |
| Sep 30, 2025 | 14.65 Mn |
| Jun 30, 2025 | 15.21 Mn |
| Mar 31, 2025 | 13.97 Mn |
| Dec 31, 2024 | 15.92 Mn |
| Sep 30, 2024 | 17.03 Mn |
| Jun 30, 2024 | 22.11 Mn |
| Mar 31, 2024 | 25.03 Mn |
| Dec 31, 2023 | 25.89 Mn |
| Sep 30, 2023 | 12.08 Mn |
| Jun 30, 2023 | 9.15 Mn |
| Mar 31, 2023 | 10.94 Mn |
| Dec 31, 2022 | 159.46 Mn |
| Dec 31, 2020 | 6.25 Mn |
| Sep 30, 2020 | 5.31 Mn |
| Jun 30, 2020 | 4.85 Mn |
| Mar 31, 2020 | 4.95 Mn |
| Dec 31, 2019 | 81.96 Mn |
API Access
Enliven Therapeutics Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=ELVN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "ELVN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=ELVN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();